((This NOV 19 story corrects to show Merck is Palantir’s exclusive partner within the JV, not for all of Palantir’s healthcare activities, paragraph 11)) By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) – Palantir Technologies Inc will set up a cancer data analytics joint venture with German lab supplies company Merck KGaA, as the U.S. analytics […]

To the Editor: Re “Trump Surveys the Ashes: ‘This Was a Really, Really Bad One’” (news article, Nov. 18): The merits and wisdom of President Trump’s policies and agenda can be debated with widely divergent perceptions among fair-minded observers. But nowhere are his shortcomings more glaring than in his symbolic, but very real, role, as […]

(Reuters) – Colfax Corp (CFX.N) made a big bet on the medical device industry with its $3.15 billion purchase of DJO Global Inc, but its shares fell 15.2 percent as investors worried about its shift away from its industrial roots to a completely new sector. Colfax said it is exploring strategic options, including a sale, […]

A week before the midterm elections, the president of the United States announced he would deploy up to 15,000 active duty military troops to the United States-Mexico border to confront a menacing caravan of refugees and asylum seekers. The soldiers would use force, if necessary, to prevent such an “invasion” of the United States. Mr. […]

HONG KONG — For years, this city was neither genuinely democratic nor entirely authoritarian. Its politics had both democratic and authoritarian elements, though on balance those were more democratic than authoritarian. Hong Kong’s “one country, two systems” arrangement with the Chinese government in Beijing afforded it a high degree of autonomy. The territory was able […]

(Reuters) – Zayo Group Holdings Inc. (ZAYO.N) has received takeover interest from a group of investors including funds managed by Blackstone Group LP (BX.N) and Stonepeak Partners LP, Bloomberg reported on Sunday, citing people with knowledge of the matter. Also part of the group that has expressed interest in a take-private deal for Zayo, which […]

Democrats won’t be able do much policymaking over the next two years, because of President Trump and the Republican Senate. But they can still use their House majority to do more than investigate Trump. Democrats can hold hearings and pass bills that make clear their party’s vision for 2020 and beyond. They can figure out […]

LONDON — I am scared. The markets are scared. The politicians I have been talking to are scared, or livid. A few days ago, Prime Minister Theresa May unveiled her deal with the European Union. Within 48 hours, Britain’s government spun into crisis. Mrs. May’s survival is threatened as furious prominent Brexiteers go public with […]

To the Editor: Re “Delay, Deny, Deflect: How Facebook Leaders Leaned Out in Crisis” (front page, Nov. 15): Perhaps we should add “Destroy” to the alliteration. Did we expect a generation of younger corporate owners and investors, having made their money so large and fast, to somehow live up to the values expressed in their […]

This morning, a long red shadow stretched over my desk. The sun rose with the unsettling neon color of an orange highlighter; the shifty outdoor air, with its brownish-blue tint, subtly promising another day of toxic air, of sour smoke. Like much of fire-ravaged Northern California, my hometown is engulfed in a smoggy haze. A […]